News

The majority of Teva's business lies in generic and off-patent branded drugs which faces price and volume pressures that will be exacerbated as regulatory actions and other players in the drug supply ...
The panel was part of the 47th annual Sapics Conference, attended by more than 700 supply chain professionals from across ...
Q2 2025 Earnings Conference Call July 31, 2025 8:30 AM ETCompany ParticipantsAnn M. Dennison - Executive VP & CFOBrian C.
But as she explained, African-led innovators are working to close these gaps through technology, data and new business models ...
In the first part of her Pharma Commerce video interview, Heather Zenk, Cencora’s president of supply chain operations & ...
July 7 – With a 90-day negotiating period on country-specific US tariffs is set to expire on July 9, Trump enacts a multitude ...
Steve Collis’ three decades of experience at a major drug distributor could prove helpful for Elevance as it continues to ...
Powerful new medications such as Ozempic and Mounjaro, known as GLP-1 drugs are helping to win the war against obesity in ...